Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2 Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

NCT03947385 is registered in ClinicalTrials.gov with IDEAYA Biosciences as lead sponsor.

NCT NCT03947385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03947385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2 Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Lead sponsor
IDEAYA Biosciences
Phase
Phase 1/2
Overall status
Recruiting
Start date
June 28, 2019
Completion date
June 15, 2027
Enrollment
336 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, cutaneous melanoma, metastatic uveal melanoma, other solid tumors